Cancer medicines

Acalabrutinib

Acalabrutinib

A BTK-targeted medicine for CLL/SLL and selected mantle cell lymphomas.

Sources checked · Introductory guide

On this page

How it works

It blocks BTK signaling to inhibit malignant B-cell growth.[3]

Where it is used

Used in selected CLL/SLL or mantle cell lymphoma with regimen and prior treatment reviewed.[1]

Key safety points

Report fever, severe bleeding, palpitations or faintness immediately. Discuss surgery, dental procedures and all medicines in advance.[2]

Questions for your care team

  • What combination, infection or bleeding prevention and procedure plan apply to me?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Acalabrutinib Maleate Monohydrate (opens in a new tab)
  2. MedlinePlus · Acalabrutinib Maleate Monohydrate (opens in a new tab)
  3. NCI Drug Dictionary · Acalabrutinib Maleate Monohydrate (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

Acalabrutinib | Cancer Encyclopedia | My Chemo Diary